Rythmol SR Related Published Studies
Well-designed clinical trials related to Rythmol SR (Propafenone)
Comparative bioavailability of propafenone after administration of a magistral suspension vs. commercial tablets in healthy volunteers. [2009]
Efficacy and tolerability of oral propafenone versus quinidine in the treatment of recent onset atrial fibrillation: A randomized, prospective study. [2009]
Propafenone for the prevention of atrial tachyarrhythmias after cardiac surgery: a randomized, double-blind placebo-controlled trial. [2008.07]
Propafenone for the Prevention of Atrial Tachyarrhythmias After Cardiac Surgery: A Randomized, Double-blind Placebo-controlled Trial. [2008.01.02]
Propafenone added to ibutilide increases conversion rates of persistent atrial fibrillation. [2006.05]
Utility of adjunctive single oral bolus propafenone therapy in patients with atrial defibrillators. [2006.03]
Comparison of intravenous ibutilide vs. propafenone for rapid termination of recent onset atrial fibrillation. [2005.12]
[Immediate cardioversion of atrial fibrillation and atrial flutter lasting less than 90 days by ibutilide versus propafenone: a multicenter study] [2005.03.30]
Clinical comparison of ibutilide and propafenone for converting atrial flutter. [2005.01]
Sotalol versus propafenone for long-term maintenance of normal sinus rhythm in patients with recurrent symptomatic atrial fibrillation. [2004.12.15]
Effectiveness of oral propafenone for the prevention of atrial fibrillation after coronary artery bypass grafting. [2004.09.01]
[Intravenous propafenone for conversion of atrial fibrillation in the emergency room] [2004.07]
Efficacy of propafenone for maintaining sinus rhythm in patients with recent onset or persistent atrial fibrillation after conversion: a randomized, placebo-controlled study. [2004.06]
Long-term maintenance of normal sinus rhythm in patients with current symptomatic atrial fibrillation: amiodarone vs propafenone, both in low doses. [2004.02]
Efficacy and safety of sustained-release propafenone (propafenone SR) for patients with atrial fibrillation. [2003.10.15]
Propafenone versus ibutilide for post operative atrial fibrillation following cardiac surgery: neither strategy improves outcomes compared to rate control alone (the PIPAF study). [2003.03]
Efficacy and safety of propafenone sustained release in the prophylaxis of symptomatic paroxysmal atrial fibrillation (The European Rythmol/Rytmonorm Atrial Fibrillation Trial [ERAFT] Study). [2002.12.15]
Long-term efficacy and safety of propafenone and sotalol for the maintenance of sinus rhythm after conversion of recurrent symptomatic atrial fibrillation. [2001.09.15]
Efficacy and safety of dofetilide in the prevention of symptomatic episodes of paroxysmal supraventricular tachycardia: a 6-month double-blind comparison with propafenone and placebo. [2001.07]
[Effectiveness and side effects of the treatment with propafenone and flecainide for recent-onset atrial fibrillation] [2001.01]
Control of paroxysmal atrial fibrillation recurrence using combined administration of propafenone and quinidine. [2000.12.15]
Comparison of intravenous flecainide, propafenone, and amiodarone for conversion of acute atrial fibrillation to sinus rhythm. [2000.11.01]
Amiodarone, sotalol, or propafenone in atrial fibrillation: which is preferred to maintain normal sinus rhythm? [2000.11]
Intravenous versus oral initial load of propafenone for conversion of recent-onset atrial fibrillation in the emergency room: a randomized trial. [2000.07]
Is there a synergic effect of propafenone associated with atrial overdrive pacing for atrial arrhythmia prevention? A randomised crossover study. [2000.02]
Comparison of oral loading dose of propafenone and amiodarone for converting recent-onset atrial fibrillation. PARSIFAL Study Group. [1999.11.01]
Comparison of propafenone versus procainamide for the acute treatment of atrial fibrillation after cardiac surgery. [1999.08.01]
Amiodarone versus propafenone for conversion of chronic atrial fibrillation: results of a randomized, controlled study. [1999.03.15]
Safety of oral propafenone in the conversion of recent onset atrial fibrillation to sinus rhythm: a prospective parallel placebo-controlled multicentre study. [1999.02.28]
Randomized, crossover, controlled comparison of oral loading versus intravenous infusion of propafenone in recent-onset atrial fibrillation. [1998.11]
Stereoselective steady state disposition and action of propafenone in Chinese subjects. [1998.11]
Intravenous propafenone versus intravenous amiodarone in the management of atrial fibrillation of recent onset: a placebo-controlled study. [1998.11]
Propafenone versus procainamide for conversion of atrial fibrillation to sinus rhythm. [1998.10]
Comparison between propafenone and digoxin administered intravenously to patients with acute atrial fibrillation. PAFIT-3 Investigators. The Propafenone in Atrial Fibrillation Italian Trial. [1998.09.01]
[Double-blind randomized placebo-controlled study of the effects of slow release and immediate release forms of propafenone in patients ventricular extrasystole symptoms] [1998.06]
Intravenous propafenone for converting recent onset atrial fibrillation in emergency departments: a randomized placebo-controlled multicenter trial. FAPS Investigators Study Group. [1998.05]
Value of single oral loading dose of propafenone in converting recent-onset atrial fibrillation. Results of a randomized, double-blind, controlled study. [1997.10]
Preliminary study of the effects of metoprolol and propafenone on ventricular arrhythmia with positive ventricular late potential. [1997.09]
The influence of atenolol and propafenone on QT interval dispersion in patients 3 months after myocardial infarction. [1997.09]
Oral propafenone to convert recent-onset atrial fibrillation in patients with and without underlying heart disease. A randomized, controlled trial. [1997.04.15]
Comparisons of oral propafenone and sotalol as an initial treatment in patients with symptomatic paroxysmal atrial fibrillation. [1997.04.01]
Propafenone during acute myocardial ischemia in patients: a double-blind, randomized, placebo-controlled study. [1997.03.01]
Efficacy of intravenous propafenone in termination of atrial flutter by overdrive transesophageal pacing previously ineffective. [1997.02.15]
Propafenone for conversion and prophylaxis of atrial fibrillation. Propafenone Atrial Fibrillation Trial Investigators. [1997.02.15]
Conversion of recent onset atrial fibrillation to sinus rhythm using a single oral loading dose of propafenone: comparison of two regimens. [1997.01.03]
Conversion of recent onset atrial fibrillation with single loading oral dose of propafenone: is in-hospital admission absolutely necessary? [1996.11]
Type II atrial flutter interruption with transesophageal pacing: use of propafenone and possible change of the substrate. [1996.11]
[Cibenzoline versus propafenone by the oral route for preventing recurrence of atrial arrhythmia: multicenter, randomized, double-blind study] [1996.10]
Effects of oral propafenone administration before electrical cardioversion of chronic atrial fibrillation: a placebo-controlled study. [1996.09]
Effects of oral propafenone on defibrillation and pacing thresholds in patients receiving implantable cardioverter-defibrillators. Propafenone Defibrillation Threshold Investigators. [1996.08]
Intravenous propafenone: efficacy and safety in the conversion to sinus rhythm of recent onset atrial fibrillation--a single-blind placebo-controlled study. [1996.05]
Propafenone versus disopyramide for maintenance of sinus rhythm after electrical cardioversion of chronic atrial fibrillation: a randomized, double-blind study. PRODIS Study Group. [1996.05]
Intravenous propafenone in paroxysmal atrial fibrillation: a randomized, placebo-controlled, double-blind, multicenter clinical trial. Paroxysmal Atrial Fibrillation Italian Trial (PAFIT)-2 Investigators. [1996.05]
[Propafenone and sotalol: long-term efficacy and tolerability in the prevention of paroxysmal atrial fibrillation. A placebo-controlled double-blind study] [1996.04]
Comparisons of oral propafenone and quinidine as an initial treatment option in patients with symptomatic paroxysmal atrial fibrillation: a double-blind, randomized trial. [1996.03]
[A comparison between propafenone and hydroquinidine perorally in the treatment of recent-onset atrial fibrillation] [1996.03]
The efficacy and safety of intravenous propafenone versus intravenous amiodarone in the conversion of atrial fibrillation or flutter after cardiac surgery. [1996.02]
[Facilitating effect of propafenone pretreatment in the interruption of atrial flutter by transesophageal pacing] [1996.02]
Comparison of the safety and efficacy of flecainide versus propafenone in hospital out-patients with symptomatic paroxysmal atrial fibrillation/flutter. The Flecainide AF French Study Group. [1996.01.25]
Safety of long-term flecainide and propafenone in the management of patients with symptomatic paroxysmal atrial fibrillation: report from the Flecainide and Propafenone Italian Study Investigators. [1996.01.25]
Are there stereoselective electrophysiologic effects of intravenously administered (S)- or (R)-propafenone hydrochloride in patients with supraventricular tachycardia? [1996]
Atrial flutter termination by overdrive transesophageal pacing and the facilitating effect of oral propafenone. [1995.12.15]
Safety of flecainide versus propafenone for the long-term management of symptomatic paroxysmal supraventricular tachyarrhythmias. Report from the Flecainide and Propafenone Italian Study (FAPIS) Group. [1995.12]
[Therapy of arrhythmia induced by myocardial ischemia. Association of L-carnitine, propafenone and mexiletine] [1995.12]
Effectiveness of intravenous propafenone for conversion of recent-onset atrial fibrillation: a placebo-controlled study. [1995.11]
[Propafenone and flecainide in the therapy of ventricular arrhythmias] [1995.10]
Propafenone for conversion of recent-onset atrial fibrillation. A controlled comparison between oral loading dose and intravenous administration. [1995.08]
[The bioequivalence of two oral propafenone preparations] [1995.05]
Steady-state plasma kinetics of slow-release propafenone, its two isomers and its main metabolites. [1995.03]
Intravenous amiodarone vs propafenone for atrial fibrillation and flutter after cardiac operation. [1995]
Comparison of propafenone to atenolol for the prophylaxis of postcardiotomy supraventricular tachyarrhythmias: a prospective trial. [1995]
Efficacy of ajmaline and propafenone in patients with accessory pathways: a prospective randomized study. [1994.10]
[A comparison between propafenone and amiodarone in the conversion to sinus rhythm of atrial fibrillation of recent onset] [1994.06]
An enantiomer-enantiomer interaction of (S)- and (R)-propafenone modifies the effect of racemic drug therapy. [1994.05]
A controlled study on oral propafenone versus digoxin plus quinidine in converting recent onset atrial fibrillation to sinus rhythm. [1994.03.01]
Partial reversal by exercise of protective effect in atrial fibrillation inducibility in patients with an accessory atrioventricular connection: comparison between flecainide and propafenone. [1994.02]
Quinidine-enhanced beta-blockade during treatment with propafenone in extensive metabolizer human subjects. [1994.01]
[Treatment of chronic ventricular extrasystole by propafenone (600 mg/d) in 2 or 3 daily doses] [1993.05]
Effects of flecainide and propafenone on systolic performance in subjects with normal cardiac function. [1993.04]
Propafenone versus sotalol for suppression of recurrent symptomatic atrial fibrillation. [1993.03.01]
[The evaluation of the antiarrhythmic activity of L-carnitine and propafenone in ischemic cardiopathy] [1993.02]
Acute pharmacologic conversion of atrial fibrillation and flutter: the role of flecainide, propafenone, and verapamil. [1992.08.20]
Washout of long-term treatment with flecainide and propafenone in patients with complex ventricular arrhythmias and cardiac disease. Antiarrhythmic Drug Evaluation Group. [1992.08]
[Comparison of the efficacy/tolerability ratio of cibenzoline and propafenone in the treatment of ventricular arrhythmia] [1992.04]
[Propafenone versus hydroquinidine in long-term pharmacological prophylaxis of atrial fibrillation] [1992.02]
A comparison of intravenous propafenone and flecainide in the treatment of tachycardias associated with the Wolff-Parkinson-White syndrome. [1991.11]
Concentration-effect relations of 5-hydroxypropafenone in normal subjects. [1991.05.01]
Propafenone treatment of symptomatic paroxysmal supraventricular arrhythmias. A randomized, placebo-controlled, crossover trial in patients tolerating oral therapy. [1991.04.01]
Comparative evaluation of verapamil, flecainide and propafenone for the acute conversion of atrial fibrillation to sinus rhythm. [1990.09.14]
Comparison of the pharmacodynamic effects of intravenous and oral propafenone. [1990.09]
Different stereoselective effects of (R)- and (S)-propafenone: clinical pharmacologic, electrophysiologic, and radioligand binding studies. [1990.06]
Propafenone versus amiodarone in field treatment of primary atrial tachydysrhythmias. [1990.01]
Propafenone versus quinidine slow-release for the treatment of chronic ventricular arrhythmias. [1990]
Pharmacokinetic and pharmacodynamic evaluation of propafenone in patients with ventricular arrhythmia. Propafenone Research Group. [1989.05]
Usefulness of propafenone for recurrent paroxysmal atrial fibrillation. [1989.04.01]
Electrophysiologic effects of intravenous propafenone in Wolff-Parkinson-White syndrome. [1989.02]
Effects of propafenone on ventricular arrhythmias: double-blind, parallel, randomized, placebo-controlled dose-ranging study. [1988.12]
Comparative pharmacokinetics and clinical pharmacology of propafenone enantiomers after oral administration to man. [1988.11]
[Diprafenone--comparative study of anti-arrhythmia therapy with propafenone] [1988.07]
Propafenone versus disopyramide for treatment of chronic symptomatic ventricular arrhythmias. A multicenter study. [1988]
Randomized placebo-controlled trial of propafenone for treatment of atrial tachyarrhythmias after cardiac surgery. [1987.11]
|
